Arrhythmogenic Right Ventricular Cardiomyopathy: Is It a Terminal Illness?

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), often referred to as a type of terminal illness, is primarily an inherited genetic disorder. Currently, there is no known cure or definitive treatment available worldwide.

Understanding the Severity of ARVC

ARVC typically leads to the deterioration of the right ventricle, resulting in severe arrhythmias that can be life-threatening. These irregular heartbeats may cause sudden cardiac arrest, which is often the primary cause of mortality among patients.

Common Symptoms of Right Ventricular Cardiomyopathy

Patients may experience a variety of symptoms, including chest tightness, shortness of breath, palpitations, and even fainting. These symptoms are usually linked to right-sided heart failure. Additionally, signs such as an enlarged liver and spleen, abdominal fluid accumulation (ascites), and swelling in both lower limbs (edema) are common due to impaired right heart function.

Managing the Condition

Once a diagnosis of right ventricular cardiomyopathy is confirmed, the focus of treatment shifts toward extending the patient's lifespan. Medical therapies often include the use of medications to strengthen heart function, diuretics to reduce fluid buildup, and supplements aimed at supporting heart muscle health. These approaches are essential for maximizing survival and improving the quality of life for patients living with this condition.